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KESAN PENDIDIKAN PERUBAHAN INTERVENSI GAYA HIDUP KE 
ATAS KETEGANGAN SALUR DARAH, PENANDA KERADANGAN DAN 
RISIKO METABOLIK DALAM SUBJEK BERLEBIHAN BERAT BADAN 
DAN OBES 
 
ABSTRAK 
 
Obesiti merupakan satu penyakit epidemik sedunia yang mempengaruhi hampir 
seluruh dunia. Kekerapan obesiti di Malaysia telah meningkat dengan mendadak 
dalam tempoh masa sepuluh tahun yang lepas. Obesiti meningkatkan risiko masalah 
perubatan dan penyakit kardiovaskular. Modifikasi gaya hidup melalui kombinasi 
memperbaiki pengambilan pemakanan dan peningkatan aktiviti fizikal merupakan 
kaedah penurunan berat badan yang kerap kali disyorkan.  
 
Tujuan kajian ini dijalankan adalah untuk mengetahui kesan menggunakan 
pendidikan intervensi gaya hidup ke atas penurunan berat badan dan pengukuran 
antropometrik serta ketegangan salur darah, penanda metabolik dan keradangan.  
 
Kajian ini melibatkan 25 subjek (21 perempuan, 4 lelaki; purata umur 36.8 tahun) 
yang mempunyai berat badan berlebihan dan obes yang telah menamatkan intervensi 
modifikasi gaya hidup selama sembilan bulan. Kesemua subjek menerima konsultasi 
untuk meningkatkan aktiviti fizikal dan mengubah cara pemakanan mereka 
sepanjang intervensi. Ukuran kajian dilakukan sebelum intervensi, 3 bulan, 6 bulan, 
dan sembilan bulan selepas intervensi. Tahap ketegangan salur darah diukur dengan 
xxv 
 
menggunakan parameter halaju gelombang denyutan (PWV) dan indeks augmentasi 
(AI) yang diperoleh daripada analisa gelombang denyutan (PWA). Ukuran 
antropometrik (berat, tinggi, indeks jisim badan, lilitan pinggang dan pinggul), 
komposisi badan (peratusan lemak badan dan lemak viseral), tekanan darah, profil 
lipid darah dan paras glukosa plasma semasa puasa diukur. Tahap penanda 
keradangan iaitu protin C-reaktif berkepekaan tinggi (hsCRP) dan penilaian model 
homeostasis untuk kepekaan insulin (HOMA% S), keupayaan sel merembes insulin 
(HOMA% B), dan kerintangan insulin (HOMA-IR) juga diukur dalam kajian ini.  
 
Penurunan yang signifikan dilihat pada berat badan (75.8 ± 15.1 kg vs 73.6 ± 17.1 
kg, p = 0.019), lilitan pinggang dan pinggul (89.2 ± 8.3 cm vs 86.4 ± 9.4 cm, p = 
0.013 dan 107.2 ± 10.0 vs 104.0 ± 11.8 cm, p = 0.005). Peratusan lemak badan dan 
lemak viseral turun menghampiri nilai signifikan (p = 0.058 dan p = 0.059). Bacaan 
tekanan darah sistolik aortik (p = 0.02), paras insulin semasa puasa (p = 0.001), 
HOMA% S (p = 0.003), HOMA% B (p = 0.002), HOMA-IR (p = 0.007) dan hsCRP 
(p = 0.01) bertambah baik dengan penurunan berat badan. Walaubagaimanapun, 
tiada perbezaan yang signifikan dilihat pada parameter ketegangan salur darah, 
tekanan darah brakial, glukosa plasma semasa puasa dan profil lipid darah selepas 
intervensi.  
 
Pedidikan selama sembilan bulan dalam intervensi gaya hidup telah menghasilkan 
penurunan berat badan yang kecil tetapi signifikan dan berkesan dalam menambah 
baik lilitan pinggang dan pinggul, tekanan sistolik aortik, kepekaan insulin, 
kerintangan insulin dan hsCRP.       
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EFFECTS OF MODIFIED LIFESTYLE INTERVENTION EDUCATION ON 
ARTERIAL STIFFNESS, INFLAMMATORY AND METABOLIC RISK 
MARKERS IN OVERWEIGHT AND OBESE SUBJECTS 
 
ABSTRACT 
 
Obesity is a global epidemic disease affecting almost all parts of the world. The 
prevalence of obesity has increased rapidly in the last ten years in Malaysia. Obesity 
increases the risk of medical problems and cardiovascular diseases. Lifestyle 
modification by improving dietary intake combined with increasing physical activity 
is the recommended method for the improvement in body composition.  
 
The objective of this study is to determine the effects of lifestyle intervention 
education on weight loss and anthropometric measurements, arterial stiffness, 
metabolic and inflammatory cardiovascular risk markers.  
 
This prospective intervention study involved 25 overweight and obese subjects (21 
females and 4 males; mean age 36.8 years) who completed a nine months education 
programme on modified lifestyle intervention. During the intervention, all subjects 
were regularly counselled to increase physical activity levels by Sports Science 
lecturer and to modify their diet by dietitians. Study measurements were performed 
at baseline, 3, 6, and 9 months. Arterial stiffness was estimated non-invasively using 
pulse wave velocity (PWV) and augmentation index (AI) obtained via pulse wave 
analysis (PWA). Anthropometric measurements (weight, height, body mass index, 
xxvii 
 
waist and hip circumference), body composition (body fat percentage and visceral 
fat), blood pressure, lipid profile, and fasting plasma glucose were also measured. 
Levels of the inflammatory marker, high sensitivity C-reactive protein (hsCRP) and 
homeostasis model assessment (HOMA) for insulin sensitivity (HOMA% S), insulin 
secretory capacity (HOMA% B), and insulin resistance (HOMA-IR) were also 
measured in this study.   
 
There were significant reductions in body weight (75.8 ± 15.1 kg vs 73.6 ± 17.1 kg, p 
= 0.019), waist and hip circumferences (89.2 ± 8.3 cm vs 86.4 ± 9.4 cm, p = 0.013 
and 107.2 ± 10.0 vs 104.0 ± 11.8 cm, p=0.005) after nine months intervention. Body 
fat percentage and visceral fat levels were marginally reduced (p = 0.058 and p = 
0.059). Significant improvements were seen in aortic systolic blood pressure (p = 
0.02), serum fasting insulin (p = 0.001), HOMA% S (p = 0.003), HOMA% B (p = 
0.002), HOMA-IR (p=0.007) and hsCRP (p=0.01) after 9 months. However, no 
significant differences were seen in arterial stiffness parameters, brachial blood 
pressure, fasting plasma glucose and lipid profile after intervention. 
 
Nine months lifestyle intervention education programme resulted in a small but 
significant weight loss which was associated with significant improvements in waist 
and hip circumference, systolic aortic blood pressure, insulin sensitivity, insulin 
resistance and hsCRP. 
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CHAPTER 1 
INTRODUCTION 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Background 
Obesity is a global epidemic problem that affects both developed and developing 
countries. The history of obesity started over 20 000 years ago since the Stone Ages 
(Bray, 2009). World Health Organization (WHO) had classified obesity as a global 
epidemic disease that has become a leading public health issue (WHO/IASO/IOTF, 
2000) and one of the ten most common cause of preventable health risks (Wilborn et 
al., 2005). Besides being a major risk factor for type II diabetes, coronary heart 
diseases (CHD), hypertension, stroke, osteoarthritis, gallbladder disease, sleep apnea 
and certain forms of cancer, obesity also leads to adverse effects on blood pressure, 
serum cholesterol, triglycerides and insulin resistance.  
 
In 2005, WHO reported that 1.6 billion adults aged ≥ 15 years were overweight 
(BMI 25.0 – 29.9 kg/m2) and 400 million were obese (BMI ≥ 30.0 kg/m2). In 2010, 
International Association for the Study of Obesity (IASO) and International Obesity 
Task Force (IOTF) estimated that approximately 1.0 billion adults were overweight 
(BMI 25.0 – 29.9 kg/m2) and about 475 million were obese. These figures indicated 
the increase in prevalence of obesity all over the world. The obesity prevalence in 
Malaysia increased more than triple in the last ten years (NHMS, 1996; NHMS, 
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2006). It was reported that Malaysia has the highest obesity rate in the South East 
Asia region and ranked as the sixth in the Asia-Pacific region (Mokhtar, 2011).  
 
Obesity is a non-communicable disease (NCD) that requires long term strategies for 
effective prevention and management. Lifestyle modification that consists of changes 
in dietary, physical activity and behavioural therapy is an approach in the prevention 
and management of obesity. Change in eating habits combined with increase in 
physical activity had been used widely for the management of obesity (Jones and 
Wadden, 2006) and is associated with significant reductions in metabolic risk, 
morbidity and mortality (Ross and Bradshaw, 2009). A comprehensive program of 
lifestyle modification is effective in inducing weight loss from 5% to 10% (Wadden 
et al., 2004; De Luis et al., 2008). 
 
Large arteries act as elastic cushion to reduce cardiac pulsation for maintaining a 
steady blood flow. During systole, the arterial walls expand and absorb the energy 
which is then released during diastole. The large arteries of the human body 
gradually lose their elasticity and become stiffer with increase in age.  Arterial 
stiffness is an index of vascular health that describes the rigidity of the arterial walls. 
Arterial stiffness is used in the clinical assessment of cardiovascular risk as increased 
arterial stiffness is significantly associated with cardiovascular diseases (Blacher et 
al., 1999; Mattace-Raso et al., 2006). Obesity and arterial stiffness are both 
important cardiovascular risk markers (Seifalian et al., 2010). The relationship 
between large arterial function and obesity has been investigated by Wildman et al. 
(2005) who reported a direct relationship between weight changes with pulse wave 
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velocity change. Previous studies showed that obesity impaired arterial elastic 
properties (Sivitz et al., 2007; Seifalian et al., 2010). 
 
Obesity is also characterized by low grade inflammation and insulin resistance 
(Ouchi et al., 2003; Wasir et al., 2007; Chou et al., 2009; Al-Tahami et al., 2011). 
Markers of low-grade inflammation such as C-reactive protein (CRP), tumor necrosis 
factor-α (TNF-α) and interleukin-6 (IL-6) has been reported to predict cardiovascular 
events (Koenig et al., 1999; Yudkin et al., 1999; Ridker et al., 2000). Elevated levels 
of the sensitive marker for inflammation, CRP had been found to be correlated with 
elevated BMI and cardiovascular disease risk factors (Visser et al., 1999).  
 
1.2 Rationale of the Study 
The prevalence of obesity continues to increase despite approaches to obesity 
treatment such as drug therapy, lifestyle modification and behaviour therapy. 
Lifestyle modification is a set of principles and techniques used to help subjects 
adopt improved dietary and exercise habits (Jones and Wadden, 2006). The 
principles and techniques of lifestyle modification varies, which include different 
durations and types of intervention. Most of previous lifestyle modification studies 
were conducted in short duration of interventions ranging from 8 to 24 weeks and 
mostly had exercise and dietary interventions which were structured, intense and 
monitored at a specific locations (Utzschneider et al., 2004; Dvorakova-Lorenzova et 
al., 2006; Villareal et al., 2006; Wong et al., 2006). Our study aims to help the 
subjects practise lifelong healthy lifestyle habits by educating them on modifying 
their dietary intake to practise a healthy diet and increasing their physical activity 
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levels. Education on modifying dietary intake was conducted by study dietitians 
while physical activity consultations were conducted by Sports Science lecturer and 
study investigators. The program was individualized so that  subjects can practise a 
healthy lifestyle in their own environment based on their capabilities which can be 
affected by factors such as fitness levels, age, any health limitations, societal and 
environmental influences (WHO, 2000).  
 
Obesity is associated with cardiovascular and metabolic risks (Safar et al., 2006a; 
Seifalian et al., 2010). Increased inflammation associated with obesity also 
contributes to the increase in cardiovascular and metabolic risks (Yudkin et al., 1999; 
Yudkin et al., 2000). There are so far no studies that have studied the effect of 
lifestyle modification education on anthropometric measurements, cardiovascular, 
metabolic and inflammatory risk markers in a single study. Santosa et al. (2008) 
conducted a study to achieve moderate weight loss in women by using self-directed 
diet and physical activity program. They reported that self-selected diet and 
independently conducted exercise program resulted in weight loss comparable to that 
observed in more controlled interventions. However, Santosa et al. (2008) did not 
study the effect of self-selected diet and independently conducted exercise program 
on cardiovascular, metabolic and inflammatory risk markers. These form the basis of 
conducting this study.   
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1.3 Objectives of Study 
Obesity is associated with increased arterial stiffness which is an indicator of 
vascular health as well as altered metabolic profile. Thus, the general objective of 
this study is to determine the effect of nine months lifestyle intervention education on 
cardiovascular, metabolic and inflammatory risk markers. The specific objectives of 
the current study are:  
i. To determine the effect of lifestyle intervention education on weight and 
other anthropometric measurements, 
ii. To determine the effect of lifestyle intervention education on arterial 
stiffness, assessed by pulse wave analysis (PWA) and pulse wave velocity 
(PWV), 
iii. To assess effect of lifestyle intervention education on cardiovascular 
inflammatory risk based on high sensitivity C-reactive protein (hsCRP) 
levels, 
iv. To assess effect of lifestyle intervention education on metabolic 
cardiovascular risk markers, specifically lipid profile, fasting plasma glucose, 
insulin sensitivity and resistance. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
2.1. Obesity  
The origin for the word obesity comes from Latin obesitas which means fatness or 
corpulence that is derived from obēsus (Dictionary.com). In medical definition, 
obesity is the condition characterized by excessive fat accumulation in the body 
either in the subcutaneous (Oxford, 2007a) or adipose tissues that presents a risk to 
health. Excess fat accumulation is associated with increase in size (hypertrophy) and 
number (hyperplasia) of the adipose tissue cells. Clinical obesity is considered to be 
present when a person has a body mass index (BMI) of 30 kg/m
2
 or more (Oxford, 
2007a) or body fat percentage > 25% for men and > 35% for women (CPG, 2004). 
Obesity occurs due to a complex interaction between genes and the environment. In 
most cases, obesity is a prolonged result of excess energy intake than is required for 
producing enough energy for metabolism, physical activity, growth, and sedentary 
lifestyle. However, recent evidence indicates that obesity can also be caused by 
genetic elements (Oxford, 2007a). Obesity has been acknowledged as a clinically 
important condition that is a major contributor to many chronic diseases including 
diabetes, cardiovascular diseases and cancer and aggravates numerous health 
problems, both independently and in association with other diseases (WHO, 1998). 
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2.1.1. Assessment and Classification of Overweight and Obesity 
Overweight occurs when an individual’s body weight is greater than the standard 
weight for a person of the same height. The excess weight may be from muscle, 
bone, fat or body water. Meanwhile obesity occurs when an individual has excessive 
fat accumulation, resulting in body weight more than 20% above the average for 
height, age, sex, and body type (Gale Encyclopedia of Medicine, 2008).  
 
Assessment of overweight and obese can be determined either by determination of 
total body fat or degree of abdominal obesity. Total body fat can be estimated by 
several methods including BMI, total body water, total body potassium, bio-electrical 
impedance (BIA), and dual-energy X-ray absorptiometry (DEXA). Determination of 
degree of abdominal obesity can be measured accurately by magnetic resonance 
imaging (MRI) or computed tomography (CT) and practically by anthropometric 
measurements which are waist circumference and waist-to-hip ratio (WHR). 
However, the most accurate methods to determine total body fat and degree of 
abdominal fat are expensive and not readily available for clinical practice.  
 
Overweight and obesity can be classified based on several different ways. The 
common indices used in clinical practice in classifying overweight and obesity are 
described below. 
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a) Body Mass Index  
Body mass index (BMI) is the most practical and accepted indices of obesity in 
populations and clinical practice. It is defined as weight in kilogram divided by 
height, in meter squared (kg/m
2
). BMI is now commonly used to predict obesity-
related morbidity and mortality in adults. Classification for the cut-off levels for 
overweight and obese of 25 kg/m
2
 and 30 kg/m
2 
by WHO are based on observational 
studies in Europe and United States of America (USA). From studies among Asian 
populations, the increased risk of morbidity and mortality of obese-related diseases 
begin to rise at lower BMI compared to Caucasians. This may be due to the high 
proportion of body fat in Asian populations (Tai et al., 1999; Deurenberg-Yap et al., 
2000; Deurenberg-Yap et al., 2002). It has been shown that Asian population have 
lower BMI but higher body fat percentage than Caucasians (Wang et al., 1994; 
Novotny et al., 2006). The WHO along with the International Obesity Task Force 
(IOTF) and International Association for the Study of Obesity (IASO) has redefined 
the classification of overweight and obesity using BMI for Asian population. 
However, the committee of WHO Expert Consultation 2004 recommends retaining 
the current WHO classification of BMI (WHO, 2000). The recommended BMI cut-
off points for Asians and the current WHO classification of BMI are shown in Table 
2.1.  
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Table 2.1: Classification of BMI by WHO in adult Caucasians and recommended 
classification in adults Asians  
Body weight  
classification 
WHO BMI
1 
(kg/m
2
) 
Asian BMI
2 
(kg/m
2
) 
Underweight  <18.5 <18.5 
Normal range 18.5 – 24.9 18.5 – 22.9 
Overweight  ≥25 ≥23 
Pre-obese / At risk* 25 – 29.9 23 – 24.9 
Obese I 30 – 34.9 25 – 29.9 
Obese II 35 – 39.9 ≥30 
Obese III ≥40  
Source: 
1
WHO (1998); 
2
WHO/IOTF/IASO (2000) 
* For Asians classification 
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b) Waist Circumference  
Waist circumference (WC) is a simple and practical method to measure abdominal 
obesity which is unrelated to height and strongly correlated with BMI and total body 
fat (Lean et al., 1996). Measurement of waist and hip circumference are influenced 
by dimensions of several abdominal tissues which are axial and pelvic skeleton, 
abdominal and back muscles, subcutaneous and intra-abdominal fat, solid and hollow 
abdominal viscera, blood vessels, and connective tissue (Misra et al., 2005). 
Increased waist circumference is associated with increased risk for cardiovascular 
disease and diabetes mellitus type II (DM II), dyslipidemia, and hypertension 
(NHLBI, 2000; Zhu et al., 2002; Yokoyama et al., 2007). 
 
According to WHO (1998), abdominal obesity is clinically defined as waist 
circumference greater than 94 cm in men and greater than 80 cm for women. For 
Asians, the recommended waist circumference cut-off points were ≥ 90 cm for men 
and ≥ 80 cm for women (WHO/IASO/IOTF, 2000). Table 2.2 showed the 
classification of overweight and obesity by BMI, WC and risk of co-morbidities for 
Asian. 
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Table 2.2: Classification of overweight and obesity by BMI, WC and risk of              
co-morbidities for Asian population 
Classification  BMI (kg/m
2
) Risk of co-morbidities 
Waist circumference 
Men  < 90 cm 
Women < 80 cm 
≥ 90 cm 
≥ 80 cm 
Underweight  < 18.5 Low  Increased   
Normal 18.5 – 22.9  Increased   Increased  
Overweight  ≥ 23.0    
Pre-obese  23.0 – 27.4 Increased  High 
Obese I 27.5 – 34.9 High  Very high  
Obese II 35.0 – 39.9 Very high Very high 
Obese III ≥ 40 Extremely high Extremely high 
Source: Malaysian Clinical Practice Guideline on Management of Obesity (2004) 
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c) Waist-to-Hip Ratio  
Waist-to-hip ratio (WHR), calculated as the ratio of waist circumference to hip 
circumference, is another assessment for abdominal obesity.  A high WHR (WHR > 
1.0 in men and > 0.85 in women) is accepted as one clinical method of identifying 
patients with abdominal fat accumulation over the last decade (MASO, 2005). Some 
report WHR as a better predictor of stroke, coronary heart disease, and mortality due 
to coronary heart disease than waist circumference (Misra et al., 2005). 
 
d) Body Fat Measurement 
Overweight and obesity are assessed by determination of total body fat.  
Measurement of accurate body fat content can be done by several methods but the 
techniques are often expensive and not practically used in clinical practice. Several 
methods or techniques that are used to assess exact amount of a person’s body fat are 
given below.  
 
i. Underwater Weighing  
Underwater weighing, or also known as hydrostatic weighing using Archimedes’ 
principle in determining body density. Archimedes principle states that when an 
object is immersed in a fluid, its buoyant force is equal to the weight of the fluid 
displaced by the object. Lean tissues which are muscle and bone are more dense in 
water compared to fat tissue. Thus, a person with higher percentage of fat-free mass 
will weigh more in the water and has lower body fat percentage.  Conversely, 
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persons with more fat mass will have lighter body in the water and have higher body 
fat percentage.  
 
The procedure for this method requires weighing a person on dry land, then 
immersing into a large tank of water and later on weighing again underwater. The 
body density is determined by using a standard equation. By using the body density, 
percentage of body fat can be estimated using the Siri or Brozek formula.  
Underwater weighing was considered as the gold standard for measuring body fat 
percentage.  
 
ii. Dual-Energy X-Ray Absorptiometry  
Dual-energy X-ray absorptiometry (DEXA) is a relatively new technology which is 
very precise and accurate in estimating body composition. It represents a three-
compartment model that divides the body into total body mineral, fat-free mass and 
fat tissue mass. DEXA system uses two low dose x-rays at different sources that read 
bone and soft tissues mass simultaneously. The differential of the two energies is 
used to estimate the bone mineral content and the soft tissue composition. DEXA has 
been used as the new gold standard in estimating body composition for its ease of use 
and provides a three-compartment model compared to the two-compartment model 
of underwater weighing.      
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iii. Bio-electrical Impedance Analysis  
Bio-electrical impedance analysis (BIA) is a relatively simple, quick and non-
invasive technique to estimate body composition by determining the electrical 
impedance of body tissues consisting of lean mass, fat, and water. BIA is based on 
the relationship between the volumes of the body, the height, the body 
compartments, and its impedance. The principle of BIA technique involves the 
passing of electric currents through the body at a differential rate depending on body 
composition (Dehghan and Merchant, 2008). Muscles and blood vessels are body 
tissues with high water contents that conduct electricity easily whereas body fat is a 
very poor conductor of electricity. An extremely low electrical current of 50 kHz and 
less than 500 µA is sent through the body to determine the amount of fat tissue. 
Since fat tissue is a poor electric conductor, a lot of fat will impede the current more 
than lean tissue. Estimation of the body fat percentage is based on the measurement 
of the resistance to the current.  
 
Validation for BIA to be used as an accurate assessment in estimating body 
composition has been done in previous studies. A study by Kushner et al. (1990) 
showed a highly significant correlation (r = 0.971; p = 0.007) between deuterium 
oxide dilution (D20) and BIA measured in twelve obese females. Kim et al. (2011) 
compared the eight-electrode BIA method with DEXA as reference method in the 
assessment of body composition in Korean adults. The study reported significant 
correlations between percentage of fat measured using  BIA and DEXA technique in 
men and women respectively (r = 0.956 and r = 0.960 respectively) with a total error 
of 2.1% fat in men and 2.3% fat in women. Another study done by Utter et al. (1999) 
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to determine the validity of the leg-to-leg BIA system in estimating body 
composition in obese and non-obese women. They compared the body composition 
between BIA method and underwater weighing. This study showed no significant 
difference between underwater weighing and BIA in estimating the fat-free mass of 
the obese and non-obese women. A significant correlation was found between BIA 
and underwater weighing in estimating fat-free mass for all subjects combined (r = 
0.78, p < 0.001). These studies showed that BIA is a simple, reliable yet accurate 
method of assessing body composition.  
 
iv. Skinfold Measurement 
Skinfold measurement is one common method in assessing a person’s body 
composition and body fat percentage. This technique estimates the body fat 
percentage by measuring skinfold thickness at specific locations on the body using a 
skinfold calliper. Skinfold measurement is usually taken on the right side of the body 
at three or seven sites depending upon the specific testing procedure. The skinfold 
measurement is taken by firmly grasping the skinfold between the thumb and 
forefinger and placing the calliper below the pinch site. The percentage of body fat 
can be calculated by using a software program or formulas.  
 
 
 
 
 
  
18 
 
2.1.2. Prevalence of Obesity 
Globally, the obesity rate is increasing at an alarming rate and now considered as a 
global epidemic. The latest analysis by International Association for the Study of 
Obesity/International Obesity Task Force (IASO/IOTF) in 2010 estimated that about 
1.0 billion adults are currently overweight (BMI 25 – 29.9 kg/m2) and 475 million 
are obese.  
 
In Malaysia, the prevalence of obesity almost tripled in the past 15 years. The 
National Health and Morbidity Survey (NHMS) conducted in 1996 reported that 
16.6% of Malaysian adults were overweight and 4.4% obese. The number of obese 
adults more than tripled over a decade according to the NHMS report in 2006. The 
prevalence of overweight was 29.1% and obesity was 14.0% in 2006. As per the 
WHO report in 2008, the prevalence of overweight and obesity in Malaysia were 
44.6% and 14.1% respectively. The latest prevalence of overweight and obesity was 
reported by Mohamud et al., (2011) were 33.6% and 19.5% respectively. The 
reported prevalence of overweight and obesity in Malaysia based on the WHO study 
was based on the WHO cut-off point and not based on BMI cut-off points for Asian. 
The prevalence of overweight and obesity in Malaysia would be higher if based on 
the cut-off points for Asians.   
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2.1.3. Health Risks of Obesity 
The health risks of being overweight and obese are many and varied, ranging from 
increases of risks to morbidity and mortality. Morbidity of a number of health 
conditions increases with the increment of BMI. Overweight and obesity are 
associated with hypertension, DM Type II, stroke, gallbladder disease, coronary 
heart disease, sleep apnea, osteoarthritis, and some types of cancer such as breast, 
liver, prostate, and gallbladder cancer. Obesity is also associated with complications 
of pregnancy, menstrual irregularities and psychological disorders. Table 2.3 showed 
the summary of health risks associated with being overweight and obese. 
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Table 2.3: The health risks associated with overweight and obesity 
Greatly increased 
(RR > 3) 
Moderately 
increased (RR 2-3) 
Mildly increased 
(RR 1-2) 
Type II diabetes 
mellitus 
Coronary heart 
disease 
Cancer (breast cancer 
in postmenopausal 
women, endometrial 
cancer, colon cancer) 
Gallbladder diseases Cardiac failure Reproductive hormone 
abnormalities 
Dyslipidemia Hypertension Polycystic ovarian 
syndrome 
Metabolic syndrome Osteoarthritis (knee 
and hips) 
Impaired fertility 
 
Breathlessness Hyperuricaemia and 
gout 
Low back pain 
 
Sleep apnea  Increased anaesthetic 
risk 
  Foetal defects 
associated with 
maternal obesity 
RR = relative risk  
Source: WHO (1998) 
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2.1.4. Etiology of Obesity 
Overweight and obesity results from a complex interaction between genetic 
predispotion, hormones and the environment characterized by long term energy 
imbalance. Energy imbalance may be due to excessive calorie intake, lack of energy 
expenditure and/or inherited metabolic characteristics.  
 
2.1.4.1. Genetic factors 
Genetic factors play a role in the development of overweight and obesity but the 
mechanism is still not known. Almost 30% to 40% of the variance in BMI can be 
attributed to genetics but it varies from study to study (Pi-Sunyer, 2002). Obesity can 
be either monogenic or polygenic in inheritance. Five single gene defects have been 
identified to be associated with overweight and obesity which are; 1) agouti gene, 2) 
leptin gene, 3) leptin receptor gene, 4) melanocortin-4 and melanocortin-3 receptor 
gene defects, and 5) serotonin (Vassalo, 2007). Mutations discovered in genes play 
roles in appetite control, food intake, and energy homeostasis (B.Hu, 2008). Obesity 
is also a hallmark of several genetic syndromes abnormalities caused by mutation 
abnormalities such as Prader Willi syndrome, Bardet-Biedl syndrome, Alstrom 
syndrome, Cohen syndrome, Albright’s hereditary osteodystrophy, and Carpenter 
syndrome (Farooqi and O'Rahilly, 2006; Goldstone and Beales, 2008).  
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2.1.4.2. Environmental factor 
The environment is one of the major factors contributing to being overweight and 
obese. Environmental factors primarily involve disorders in energy intake and energy 
expenditure.   
 
2.1.4.2.1. Energy Use Imbalances 
Energy is consumed through carbohydrate, protein and fat intake in the diet. Total 
energy intake refers to all energy consumed from food and drinks that can be 
metabolized inside the body (WHO, 2000). Positive energy balance occurs when 
energy intake exceeds energy expenditure. The excess calories from dietary intake 
will be converted and stored as body fat in the adipose tissue. The accumulation of 
excess body fat stored may lead to overweight and obesity (Wilborn et al., 2005). 
Lichtman et al. (1992) reported that excessive food consumption is associated with 
obesity. Conversely, negative energy balance occurs when energy intake is less than 
energy expenditure, promoting decreases in body fat and weight loss.   
 
Both in the developed and developing countries, there is an overall abundance of 
palatable and caloric-dense food. The ease in finding abundance of food which are 
available in the supermarket, fast food restaurants and even vending machines 
promote high caloric consumption (WHO, 1998). Many of the significant socio-
cultural traditions especially special occasions or holidays promote overeating and 
the preferential consumption of high calorie foods (WHO, 1998). Malaysia 
especially with a multi-racial population has many special occasions and celebrations 
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such as ‘Hari Raya’, Chinese New Year, and Deepavali. All the celebrations come 
along with abundance of food that promotes the excessive calorie intake.   
 
2.1.4.2.2. Energy Expenditure 
Energy expenditure is composed of basal metabolic rate, the thermic effect of food, 
and physical activity (Wilborn et al., 2005). The proportion to the total energy 
expenditure varies according to the regularity and intensity of physical activity. In 
sedentary adults, the basal metabolic rate contributes nearly 60% of total energy 
output, the thermic effect of food accounts around 10% and the remaining 30% from 
physical activity (WHO, 2000). The lack of physical activity or sedentary lifestyle 
also leads to overweight and obesity. The trends towards industrialization and 
modernization decrease the amount of energy expenditure. The increased utilization 
of motorized transport, mechanized equipments, and labours saving devices both in 
the home and at work limit the necessity of physical activity. These developments 
decrease work-related activity and increase sedentary daily routines consisting of 
sitting at work and sitting in front of computer or television for most of the hours 
(WHO, 1998; WHO, 2000).  
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2.1.5. Management of Obesity 
Management of obesity can be either pharmacological or non-pharmacological 
interventions or both. The treatment of obesity is optional according to different 
levels of BMI and other risk factor. Table 2.4 showed the treatment options for 
different levels of BMI and other risk factors in Asians populations. The aim for the 
management of obesity is to reduce body weight, prevention of weight gain, maintain 
a lower body weight over the long term, and treat co-morbidities or underlying 
causes (CPG, 2004). The initial goal of obesity management is to reduce body weight 
by 10% from baseline (CPG, 2004). Randomized controlled trials showed that 
weight loss from 5 to 15% reduces the risk factors of cardiovascular diseases (Wilson 
et al., 1999; Tuomilehto et al., 2001). The benefits of 10% weight loss on reducing 
cardiovascular diseases and improving health risks in obesity are shown in Table 2.5.  
 
 
 
 
 
 
 
 
 
